domingo, 10 de febrero de 2019

Why my patient advocacy organization is investing in CRISPR - STAT

Why my patient advocacy organization is investing in CRISPR - STAT

First Opinion



Why my patient advocacy organization is investing in CRISPR

By DEBRA MILLER


APSTOCK
I believe CRISPR is a weapon, but a quiet, surgically precise weapon against diseases that have long confounded the scientific community.

No hay comentarios: